
Flavia Veera Castelino MD
Scleroderma & Related
Associate Professor of Medicine, Harvard Medical School; Director, Scleroderma Program, Massachusetts General Hospital
Join to View Full Profile
55 Fruit St Yawkey 4BRheumatology Unit, Massachusetts General HospitalBoston, MA 02114
Phone+1 617-726-7938
Fax+1 617-726-2872
Dr. Castelino is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mass General Brigham/Massachusetts General HospitalFellowship, Rheumatology, 2007 - 2009
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2004 - 2007
- SUNY Upstate Medical UniversityClass of 2004
Certifications & Licensure
- MA State Medical License 2007 - 2025
- IL State Medical License 2004 - 2007
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow American College of Rheumatology
- Walter Coyle Memorial Award Scleroderma Foundation
Clinical Trials
- A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis Start of enrollment: 2014 Sep 01
Publications & Presentations
PubMed
- Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States.Yiming Luo, Shervin Assassi, Maureen D Mayes, Tracy M Frech, Virginia D Steen
Annals of the American Thoracic Society. 2025-04-10 - 1 citationsSerum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort study.Monique Hinchcliff, Dinesh Khanna, Enrico De Lorenzis, Stefano Di Donato, Antonio Carriero
The Lancet. Rheumatology. 2025-03-31 - Belumosudil in diffuse cutaneous systemic sclerosis: a randomised, double-blind, open-label extension, placebo-controlled, Phase 2 study.Lorinda Chung, Richard M Silver, Virginia Steen, Daniel E Furst, Flavia V Castelino
Rheumatology. 2025-03-14
Press Mentions
- ICU Acquired Decubitus Ulcers: Prevention and Early InterventionJune 22nd, 2024
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: